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Applications ranging from synthetic biology to pro-
tein crystallization could be advanced by facile sys-
tems for connecting multiple proteins together in
predefined spatial relationships. One approach to
this goal is to engineer many distinct assembly forms
of a single carrier protein or scaffold, to which other
proteins of interest can then be readily attached. In
this workwe choseGFP as a scaffold and engineered
many alternative oligomeric forms, driven by either
specific disulfide bond formation or metal ion addi-
tion. We generated a wide range of spatial arrange-
ments of GFP subunits from 11 different oligomeric
variants, and determined their X-ray structures in a
total of 33 distinct crystal forms. Some of the oligo-
meric GFP variants show geometric polymorphism
depending on conditions, while others show consid-
erable geometric rigidity. Potential future applica-
tions of this system are discussed.
INTRODUCTION
The general idea of connecting and spatially organizing multiple
proteins is an emerging theme in synthetic biology. Notable
applications include the spatial organization of multiple enzymes
for metabolic pathway optimization (Conrado et al., 2008;
Dueber et al., 2009; Lee et al., 2012), the organization of signaling
molecules (Good et al., 2011; Zeke et al., 2009), and the creation
of large self-assembling protein architectures (Lai et al., 2012).
Another area under exploration is the synthetic organization of
protein molecules into various symmetric forms to expand the
chances of being able to induce them to form well-ordered crys-
tals (Laganowsky et al., 2011). Facile systems for enabling the
specific spatial organization of arbitrary proteins of interest could
therefore advance research along various lines.
Ongoing efforts toward engineering proteins for improved
crystallization stem from the generally low success rate and
unpredictability of macromolecular crystallization (Sundstrom
et al., 2006; Stacy et al., 2011). Regardless of the varied explana-
tion for why many proteins are difficult to crystallize, the chances
for a successful outcome might be improved by promoting the1754 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltformation of intermolecular contacts that are compatible with
crystal symmetry. Various methods for engineering proteins to
improve their likelihood of forming good crystal contacts through
surface residuemutations or fusion to a carrier protein have been
described and reviewed (Banatao et al., 2006; Derewenda and
Vekilov, 2006; Salgado et al., 2008; Forse et al., 2011; Corsini
et al., 2008; Moon et al., 2010; Zou et al., 2012) including fusion
to engineered GFPs (Suzuki et al., 2010).
Synthetic symmetrization, the engineering of artificially sym-
metric forms of a given protein molecule, has been promoted
as one method for explicitly increasing the likelihood that a pro-
tein will be able to form a crystal lattice (Banatao et al., 2006).
Two potential advantages have been articulated. First, geomet-
ric arguments and analysis of observed crystallization patterns
suggests that a modest advantage can be gained by building
symmetry into an otherwise asymmetric protein molecule by
forcing it to oligomerize. Second and perhaps more important,
the ability to produce multiple distinct symmetric forms of a
target protein is a major advantage for crystallization. If the pro-
tein under study is the subject of crystallization trials, then each
of the oligomeric constructs (e.g. specific dimers) is in effect a
distinct molecular species with new opportunities to form lattice
contacts in the context of a crystal. Distinct dimeric forms of a
protein, for example, can be constructed by introducing single
cysteine residues at various surface-exposed residues in a
protein (Banatao et al., 2006; Forse et al., 2011). In another
approach, metal-binding half-sites can be designed by intro-
ducing two potential metal-ligating residues (e.g. histidines) at
proximal positions on the protein surface (Laganowsky et al.,
2011). These experiments have shown that proteins engineered
in such ways form oligomers that are rigid enough for facile crys-
tallization, and that many new opportunities are opened up for
the crystallization of a single given protein. In many cases, the
new interactions introduced into the target protein contribute
to the symmetry of the crystal (Banatao et al., 2006; Chruszcz
et al., 2008).
Despite the potential for synthetic symmetrization to expand
the opportunities for growing protein crystals, the method as
it has been applied so far is experimentally burdensome. Its
advantages are offset by the need to engineer multiple variants
of the target protein, whose structure may be unknown, leading
to potential challenges in conferring favorable properties without
disrupting its fold. In this study, we explore a route for circum-
venting this obstacle. The essential idea is to apply the protein
engineering work (i.e. to introduce varied forms of syntheticd All rights reserved
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Figure 1. Concept of Scaffold-Mediated Synthetic Symmetrization
Here, GFP serves as a scaffold to induce synthetic symmetry. (Top) Multiple
modes for attaching a target protein to GFP are indicated, including simple
fusion and split-form complementation where the target protein is fused to a
fragment of GFP, either strand 11 or strands 10–11. (Bottom) GFP (or another
scaffold) is engineered in multiple ways to create varied oligomeric forms.
When a target protein is connected (by fusion or complementation) to the
engineered GFP molecules, varied oligomeric forms of the target protein are
created.symmetrization) to a model protein that can subsequently serve
as a general carrier or scaffold for attaching otherwise arbitrary
proteins. In this way a target protein can be driven into varied
oligomeric forms with distinct opportunities to crystallize,
without having to substantially compromise its native sequence.
As long as the target protein is notmuch smaller than the scaffold
to which it is attached, both components can be expected to
participate in ordered contacts in a crystal.
Multiple strategies are possible for attaching a target protein
to a scaffold protein, including by direct genetic fusion. Other
possibilities are presented by a scaffold that can be produced
and then reconstituted from two separate fragments. Here, we
investigate the use of GFP as a scaffold for oligomerization, since
GFP, particularly when accompanied by stabilizing mutations,
can be expressed in split form and then functionally reconsti-
tuted from a large fragment and a small fragment (Cabantous
et al., 2005, 2013; Huang and Bystroff, 2009; Nguyen et al.,Structure 23, 1754–172014). The key elements of the approach are illustrated in
Figure 1. The use of monomeric split-GFP to complement and
then crystallize another protein that is fused to the small GFP
fragment has been already demonstrated in recent work
(Nguyen et al., 2014). Here, the oligomerization element of
the overall strategy is demonstrated by the construction and
crystallographic investigation of several engineered variants of
GFP. This large suite of engineered GFP proteins provides
a foundation for various future developments, including those
in the broad area of synthetic biology as well as in protein
crystallization.
RESULTS
Rationale for GFP-Mediated Symmetrization
Engineered ‘‘split’’ forms of GFP have gained widespread use
in the laboratory setting as biosensors (March et al., 2003) or
fusion partners to probe for protein solubility (Cabantous
et al., 2005, 2013). These mutants of GFP can be expressed
without one or more terminal b strands of the 11 strands
composing the GFP b barrel. Using circular permutants of a
full-length GFP containing mutations developed for the split
form of GFP (Cabantous et al., 2005), Huang and Bystroff
(2009) created additional split-GFP pairs (with other tagging
or ‘‘left-out’’ strands such as b strand 7). The partial core can
then be complemented by addition of another protein that
has been engineered to carry the missing GFP b strand(s), as
either a terminal fusion or a loop insertion. Once complementa-
tion occurs the full b barrel is restored, and formation of the
native chromophore provides a convenient readout of complex
formation.
These previous developments make GFP well suited as a
general carrier protein for implementing a new approach to the
idea of synthetic symmetrization. The particular form of GFP
used in our study can be split after strand 9, resulting in the
GFP (strands 1–9) core and GFP (strands 10–11) hairpin (Caban-
tous et al., 2005; Nguyen et al., 2014). With this system, the
hairpin formed by strands 10 and 11 can be engineered into a
target protein, which will then complement GFP(1–9). In the
simplest scenario, the (10–11) hairpin can be fused as an exten-
sion at either the N or C terminus of the target protein. However,
the two-stranded hairpin allows for another particularly advanta-
geous kind of construction. If the hairpin can be inserted at an
internal sequence position on an exposed loop in the target pro-
tein, then the protein complex formed upon complementation
will possess a two-chain crossing between the reconstituted
GFP domain and the target protein structure (Figure 1). This
is expected to enforce a much more rigid spatial arrangement
between the two components, which could be an advantage,
particularly where crystallization is the ultimate goal. In fact this
has been demonstrated in one recent study, where a crystal
structure revealed two copies of the molecular complex in the
asymmetric unit in very nearly the same configuration, suggest-
ing a limited range of motion when using the (10–11) hairpin
insertion approach (Nguyen et al., 2014). Anticipating the ulti-
mate advantage of the GFP(1–9) plus (10–11) hairpin approach,
we focused our efforts on engineering oligomerizing variants
of GFP in the strand 1–9 core region at positions remote from
the (10–11) hairpin.68, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1755
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Figure 2. Locations of Point Mutations Intro-
duced on Full-Length Split-GFP to Induce
Oligomerization
(A) Locations of the individual point mutations to
cysteines (yellow) on the GFP(1–9) core (green) on
the opposite face of the b barrel from theGFP(10–11)
hairpin (red).
(B) Each cysteine point mutant was purified in
non-reducing conditions, and dimer formation was
visualized on a non-reducing SDS-PAGE gel. After
an initial IMAC step, GFP variants were dimerized
with Cu2+. The dimeric form, D, was then separated
from the monomer, M, via anion exchange chro-
matography and used for crystallization experi-
ments.
(C) Locations of the metal-half-site mutations on
GFP (yellow, orange or blue); each site involves a
pair of spatially proximal mutations (indicated). Color
coding as in (A).
(D) Native PAGE screening of each metal-chelating
mutation in the presence of Cu2+, Ni2+, and Zn2+.
This screen showed apparent oligomer formation for
the D21H/K26C, E115C/T118H, E124H/K126H, and
E124H/K126C variants, as determined by a mobility
shift from the monomeric (M) band to the assumed
oligomeric (O) band.Design and Structure of Cysteine-Based GFP Dimers
In our first approach to engineering oligomerizing variants of
GFP, individual cysteine residues were introduced at surface po-
sitions. Each such engineered protein was expected to produce
a distinctly different dimeric structure upon oxidative disulfide
formation. The utility of the disulfide-based approach to syn-
thetic symmetrization has been demonstrated previously (Bana-
tao et al., 2006; Forse et al., 2011). For application of the idea to
GFP, we created five cysteine point mutations—K26C, D102C,
D117C, Q157C, and D190C—as well as two sets of mutations
to serve as either disulfide or metal-mediated oligomers (dis-
cussed subsequently): E115C/T118H and E124H/K126C. These
amino acids were selected for mutation based on their polarity,
surface location, and distance from strands 10–11 in order to
limit interference with complementation when ultimately ex-
pressed in the split form (Figure 2). As the starting or wild-type
sequence for design of the point mutations, we chose the
sequence of split-GFP in its full-length form (Cabantous et al.,
2013) using the superfolder GFP structure as a reference for
point mutations in solvent-exposed locations (Pe´delacq et al.,
2006). Two native cysteines at positions C48 and C70 were first
mutated to alanine to prevent subsequent interference with
disulfide-based dimerization; one exception was an initial exper-
iment and crystal structure of the K26Cmutant of the superfolder
form (PDB: 4W6B) in which only the cysteine at position 48 had
been removed. The ultimate goal of our study is to use engi-
neered versions of the truncated GFP(1–9) to synthetically
symmetrize target proteins bearing the (10–11) hairpin, but we
judged it prudent to first conduct the GFP engineering experi-
ments against the background of the complete GFP(1–11)
construct. Full-length GFP constructs bearing the single engi-
neered cysteine residue were therefore expressed, purified,
and oxidized to form homogeneous dimers (Figure 2). For all
five of the cysteine sites chosen, pure dimers could be obtained1756 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltin good yieldwith20–50mgof protein obtained from 2 l of auto-
induction media.
With the exception of Q175C, crystals grew readily in 1–
7 days. Depending on the mutant, diffraction-quality crystals
grew in as few as one condition for K126C or in more than 20
for D102C and D190C. Due to the large numbers of crystals
that grew in the initial experiments, it was not feasible to screen
X-ray diffraction in all crystals or to optimize all the crystal hits
that were observed. We took the approach of screening crystals
that appeared morphologically unique and large enough to
mount for X-ray diffraction experiments. In some cases where
initial crystals did not diffract despite having good morphology,
minor optimization was performed, but otherwise crystals were
taken directly from initial screens. Across the many crystal forms
examined for the various mutants, the diffraction resolution
ranged from 1.7 A˚ to poorer than 3.5 A˚ (Table 1). Rather than
striving to maximize the resolution for the many crystal forms
obtained, we focused on investigating the variety of crystal
packing arrangements that these dimers could explore, and
the degree to which they appeared to have well-ordered modes
of dimerization.
In addition to the cases where we intentionally designed a
disulfide bond to make GFP dimers, there were cases whereby
we had anticipated the formation of a metal-binding site be-
tween GFP monomers involving a combination of an inserted
histidine and cysteine pair, but obtained instead GFP dimers
connected by a simple disulfide bond when the metal ion
was added. These were mutant pairs D21H/K26C, E115C/
T118H, and E124H/K126C. In these cases a disulfide bond
was seen in the electron density map, but without evidence
for metal binding at the dimer interface. These fortuitous dimers
were not explored in depth to try to produce additional crystal
forms, so their abilities to form alternative crystal lattices were
not established.d All rights reserved
Table 1. Summary of New GFP Crystal Forms
PDB Mutation Type Space Group Resolution (A˚) ASUa
4W69 Q157C disulfide P 43 21 2 3.98 2
4W6A Q157C disulfide P 32 2 1 2.99 2
4W6B K26Cb disulfide P 21 21 21 1.90 2
4W6C D21H/K26Cc disulfide P 21 21 21 2.49 2
4W6D K26C disulfide P 32 2 1 3.45 2
4W6F D21H/K26C disulfide P 32 2 1 2.70 2
4W6G D190C disulfide P 61 3.02 2
4W6H D190C disulfide P 65 1.95 2
4W6I D190C disulfide P 21 21 21 2.63 2
4W6J D117C disulfide P 31 2 1 1.70 2
4W6K D117C disulfide P 41 21 2 2.88 2
4W6L D117C disulfide I 41 2 2 2.45 1
4W6M D117C disulfide P 63 2.79 4
4W6N D117C disulfide C 1 2 1 3.38 6
4W6O D117C disulfide P 64 2 2 2.60 1
4W6P D102C disulfide P 21 21 21 3.09 8
4W6R D102Cc disulfide P 1 3.47 16
4W6S D124H/K126C disulfide P 43 21 2 3.10 2
4W6T E115H/T118H Cu-mediated contacts P 43 21 2 1.60 1
4W6U E115H/T118H Ni-mediated contacts P 21 21 21 2.28 4
4W72 E115C/T118H disulfide + metal contacts P 21 21 21 1.99 2
4W73 E115C/T118H disulfide P 21 21 21 2.79 2
4W74 E115C/T118H Zn crystal contacts P 1 21 1 2.10 8
4W7X E115C/T118H disulfide P 1 21 1 2.80 4
4W75 D21H/K26Cc disulfide + metal contacts P 21 21 21 3.47 2
4W76 D21H/K26Cc disulfide + metal contacts P 21 21 21 2.35 2
4W77 D21H/K26Cc disulfide + metal contacts P 21 21 21 3.10 2
4W7A D21H/K26Cc disulfide + metal contacts P 21 21 21 3.60 4
4W7C D21H/K26Cc disulfide + metal contacts C 1 2 1 2.50 4
4W7D D21H/K26H Cu crystal contacts P 21 21 21 1.80 2
4W7E D21H/K26H Cu crystal contacts P 41 21 2 2.59 1
4W7F D124H/K126H Cu crystal contacts C 2 2 21 2.90 1
4W7R D124H/K126H Cu dimers P 1 21 1 1.80 4
aNumber of GFP chains in the asymmetric unit.
bSuperfolder GFP C48A backbone mutation.
cSplit-GFP C48A backbone mutation. All other sequences have the double mutations of C48A and C70A.In all, we were able to characterize 20 distinctly different crys-
tal forms of the GFP disulfide dimers and solve their structures
(Table 1), with an additional six dimers containing both a disulfide
bond and metal contacts. In all these structures, we modeled di-
sulfide bonds into the electron density maps where possible,
tabulating standard geometric terms and bond energies for the
observed disulfide bonds (Tables 2 and S1) (Katz andKossiakoff,
1986). In some cases where the resolution was limited this was
not possible, and in at least two cases it appeared that the disul-
fide bond had been broken during the course of the X-ray diffrac-
tion experiment due to synchrotron radiation damage, as has
been observed before (Carugo and Carugo, 2005; Weik et al.,
2000).
The occurrence of multiple crystal forms for individual mu-
tants, and the presence in several cases of multiple crystallo-Structure 23, 1754–17graphically independent GFP dimers in the unit cell, made it
possible to analyze the range of conformations and degree of
flexibility in these engineered dimers (Figure 3). An analysis of
the symmetry and variations due to disulfide bond flexibility
was performed for each cysteine mutation by comparing all
dimers that were observed for a given point mutation (Figure 4;
Table 2). In each case, we calculated the angle of rotation be-
tween the two subunits connected by the engineered disulfide
bond to judge whether the synthetically generated dimers were
nearly symmetric (i.e. related by a 180 rotation) (Table 2). Then,
to evaluate how rigidly connected the two subunits were, we
examined the degree of geometric variability between multiple
instances of the same dimer as observed across different crystal
forms or different asymmetric units of the same crystal form.
A complete analysis is provided in Tables S2 and S3, and68, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1757
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Dimer
The internal rotation axis relating the subunits of
each dimer is shown (red dot for disulfide dimers,
blue for the mixed dimer (L), and orange for the
metal-mediate dimer (C)). For each dimer the rota-
tion axis corresponds to the location of the en-
gineered disulfide bond, or metal-mediated crystal
contact.
(A–L) The 12 dimers shown are from structures
PDB: (A) 4W6B, (B) 4W6C, (C) 4W7C, (D) 4W6R, (E)
4W7X, (F) 4W6M, (G) 4W6G, (H) 4W6I, (I) 4W6S, (J)
4W69, (K) 4W6K, and (L) 4W7R. These dimers are
representative of the complete set of 43 total
dimers visualized in this work.summarized in Figure 4 and Table 2. A description of the individ-
ual disulfide-bonded GFP structures is as follows.
K26C
Four crystal forms of K26C dimers were observed (PDB: 4W6B,
4W6C, 4W6D, and 4W6F), two in each of the space groups
P212121 and P3221. Of these, PDB: 4W6C was the most sym-
metric (175.6) while PDB: 4W6F was the least symmetric
(144.3). PDB: 4W6C, 4W6D, and 4W6F were most similar to
each other with a maximum variation of 33.3, while PDB:
4W6B varied by a rotation of up to 140.4 when overlaid on the
others (Table 2; Figure 4B). Two of the structures (PDB: 4W6F
and 4W6C) in which GFP dimers were obtained through a disul-
fide bond at position 26 arose from a D21H/K26C double mutant
initially designed for metal chelation. Unexpectedly, addition of
Ni2+ resulted in formation of a disulfide bond between residues(A–G) The PDB codes for structures and dimer chains displayed are (A) K26C: red, PDB: 4W6C; blue, PDB: 4
4W7A AB dimer; blue, PDB: 4W7A CD dimer; cyan, PDB: 4W75. (C) D102C: red, PDB: 4W6P CD dimer; blue,
magenta, PDB: 4W6R KL dimer. (D) E115C: red, PDB: 4W72; blue, PDB: 4W73. (E) D117C: red, PDB: 4W6O;
PDB: 4W6J. (F) Q157C: red, PDB: 4W69; blue, PDB: 4W6A A dimers; cyan, PDB: 4W6A B dimer. (G) D190
1758 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltd All rights reserved26C from two protein molecules during
the crystallization experiments on these
variants.
D102C
Two crystal forms were observed for this
mutant, one in space group P1 (PDB:4W6R) and one in P212121 (PDB: 4W6P). Crystals appearing in
the P1 morphology (thin plates) were obtained in numerous con-
ditions containingPEGpolymers as the precipitant.Wewere able
to solve the structure of PDB: 4W6R to 3.47 A˚; this was the high-
est resolution we were able to obtain from all the crystals
screened of the D102C mutant. This P1 crystal form had a total
of eight disulfide-bonded dimers in the crystal asymmetric unit
with an average angle between the chains of 167. The eight di-
mers were remarkably similar, with a maximum angular variation
of only 8 (Figure 4C; Table 2). Due to this small range of variation,
the CCP4 program Zanuda (Winn et al., 2011) was used to inves-
tigate and rule out the possibility that some higher crystallo-
graphic symmetry had been missed in the initial structure deter-
mination. The PDB: 4W6P structure also contained four dimers in
the asymmetric unit of P212121. These dimers are less symmetricFigure 4. Chain Angle Ranges for Dimers
Depicted is the rangeof variation between thechain
orientations for eachdisulfide-bondeddimer.Chain
A of each dimer was first aligned to visualize the
difference in the orientation of the distinct versions
of chain B. Only the chain B backbone traces
are depicted. Each panel illustrates the multiple
conformations observed for one specific cysteine
mutant. Theblueand red traces represent the range
of orientations the chains adopted. When a single
outlier is found it is shown in cyan. When two
disparate groups of conformations are present
they are shown in red and blue, and cyan and
magenta.Whenmore thanonedimerwasobserved
in the asymmetric unit, instances representing
the extremes in conformation were chosen. The
rotation axis that relates the two molecules, and
which coincides roughly with the position of the
point mutation(s), is indicated by a yellow circle.
W6F; cyan, PDB: 4W6B. (B) D21H/K26C: red, PDB:
PDB: 4W6P FG dimer; cyan, PDB: 4W6R AN dimer;
blue, 4W6K; cyan, PDB: 4W6N BF dimer; magenta,
C: red, 4W6H; blue, 4W6I; cyan, 4W6G.
Table 2. GFP Disulfide Dimer Characterizations
Mutant PDB Dimer
Disulfide Ca
Distance (A˚)
Dimer
Angle () Grouped PDB Chain ‘‘B’’ Variation Range ()
K26C 4W6B AB 6.4 151.66 group:
4W6C, 4W6D, 4W6F
group
4W6C–4W6F = 33.3
maximum range:
4W6C AB 6.2 175.55
4W6D AB 6.2 158.12
4W6F AB 5.6 144.29 outlier: 4W6B 4W6B–4W6D = 140.4
D21H/K26C 4W7A AB 5.8 169.72 group:
4W7A, 4W7C, 4W76
4W77
outlier: 4W75
group:
4W7A AB–4W7A CD = 6.3
maximum range:
4W7A CD–4W75 = 32.1
4W7A CD 6.2 177.95
4W7C AB 5.9 173.38
4W7C CD 6.4 171.85
4W75 AB 6.2 151.90
4W76 AB 6.4 174.64
4W77 AV 6.1 173.00
D102C 4W6P AB 4.5 143.38 group 1:
4W6P
group 2:
4W6R
group 1:
4W6P CD–4W6P FG = 8.3
group 2:
4W6R AN–4W6R KL = 7.7
maximum range:
4W6P FG–4W6R KL = 32.4
4W6P CD 4.6 146.21
4W6P EH 4.6 143.79
4W6P FG 4.6 139.64
4W6R AN 5.2 165.37
4W6R BI 4.7 165.15
4W6R CD 4.1 170.66
4W6R EJ 4.4 167.73
4W6R FO 4.7 166.16
4W6R GO 4.9 163.96
4W6R HM 4.9 166.20
4W6R KL 4.3 170.91
E115C 4W7X AB 6.2 166.40 group:
4W7X, 4W72, 4W73
4W72–4W73 = 12.3
4W7X CD 5.4 163.93
4W72 AB 5.9 159.85
4W73 AB 6.4 170.95
D117C 4W6J AB 5.7 154.89 group 1:
4W6K, 4W6L, 4W6M
4W6O
group 2:
4W6J, 4W6N
group 1:
4W6O–4W6K = 16.4
group 2:
4W6N BF–4W6J = 10.8
maximum range:
4W6N BF–4W6M AC = 34.8
4W6K AB 5.7 166.82
4W6L AB 5.5 180.0
4W6M AC 5.6 178.44
4W6M BD 6.5 178.14
4W6N AD 6.1 148.41
4W6N BF 6.3 146.59
4W6N CE 6.4 146.87
4W6O AB 5.5 179.97
K126C 4W6S AB 6.00 177.96 – –
K126H 4W7R AB – 179.1 – AB–CD = 1.7
4W7R CD 179.15
Q157C 4W69 AB 5.5 141.18 – 4W96–4W6A B = 129
4W6A A 5.78 180.0
4W6A B 11.7a 180.0
D190C 4W6G AB 5.8 140.95 group:
4W6G, 4W6H
outlier: 4W6I
group:
4W6G–4W6H = 6.3
maximum range:
4W6H–4W6I = 41.4
4W6H AB 5.8 135.23
4W6I AB 6.4 171.21
aPotential disulfide broken during crystallization.
Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1759
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Figure 5. Observed Metal-Mediated Crystal Contacts
(A) Structure PDB: 4W72: a disulfide bond is formed in addition to the copper-binding site.
(B) Example of a mixed dimer from structure PDB: 4W76. Here the copper ion is chelated by histidine and aspartate residues from both molecules, and a disulfide
bond is also formed.
(C) The two forms of metal-mediated contacts in PDB: 4W7D.
(D) The three observed zinc-mediated contacts found in PDB: 4W74. (Left) Cys115/His118 from one chain and Cys115 from another chain chelate the zinc.
(Middle and right) Cys115/His118 from one chain chelate the zinc ion along with an aspartate (Asp190 or Asp102) from another chain.
(E) A nickel-mediated crystal contact in the structure of PDB: 4W6U involving histidines from the two proteins and a citrate molecule.
(F) A double copper-mediated crystal contact in the structure of PDB: 4W6T, both involving a combination of histidine and carboxylates.
(G) A copper-mediated crystal contact in the structure of PDB: 4W7F. His124 and His126 chelate the copper ion with Glu5 of the symmetry mate.
(H) Copper chelation by His124 and His126 of the symmetric dimer of PDB: 4W7R.than those observed in the P1 form (average internal angle be-
tween subunits of 143). In comparison with the other dimeric
forms in the same crystal asymmetric unit of this mutant, one
dimer was a minor outlier, having a relative chain rotation be-
tween subunits of 5–8. The uniqueness of this dimer effectively
rules out the possibility of any higher symmetry in the crystal.
E115C
Originally intended to serve as a metal-binding half-site, the
mutated pair of residues, E115C/T118H, revealed disulfide-
bonded dimer formation under crystallization conditions with
the addition of metal ions. Four structures were obtained: three
disulfide dimers (PDB: 4W72, 4W73, and 4W7X), and one struc-
ture with metal-mediated contacts only (PDB: 4W74, discussed
subsequently). The three disulfide dimers feature an average
rotation angle between subunits of 165, with a variation up to
12 (Figure 4E; Table 2). Interestingly, PDB: 4W72 features a
metal-mediated contact as well, involving the chelation of a cop-
per ion byHis118 of one chain A andGlu17 of another (Figure 5A).1760 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier LtD117C
Thismutant resulted in six crystal forms, each in a different space
group. The six dimers fall into two groups (Figure 4E; Table 2).
Three of the dimeric forms observed (PDB: 4W6L, 4W6M, and
4W6O) are either perfectly symmetric with the two subunits
related by crystal symmetry (PDB: 4W6L and 4W6O), or very
nearly symmetric PDB: 4W6M, 179 rotation). PDB: 4W6J and
4W6M feature similarly asymmetric dimers (average internal
angle of 149), and PDB: 4W6K contains a dimer with an internal
angle of 167. It is notable that D117C dimers are rigid enough to
form very well-ordered crystal lattices, diffracting up to 1.7 A˚. Yet
they are not locked into one conformation, and the permissible
angular variation allows for multiple distinct lattices.
K126C
An intended metal-half-site pair, E124H/K126C (PDB: 4W6S)
apparently underwent disulfide oxidation in the crystal drop,
leading to a symmetric dimer (178). Copper was added to the
protein immediately prior to the crystallization experiment, andd All rights reserved
no copper ions were observed in the crystal structure. No further
efforts were undertaken to explore the possibility of additional
space groups for this dimer.
Q157C
Two structures were solved from this mutant (PDB: 4W69 and
4W6A), and only after screening andoptimization of crystal condi-
tions. This is likely a result of the pointmutation being located on a
somewhat flexible loop of the GFP core. The best crystals dif-
fracted to a resolution of 4 A˚ (PDB: 4W69). PDB: 4W6A represents
an interesting and somewhatmysterious crystal form. Twochains
are in the asymmetric unit, and they contribute to two different
symmetric dimers sitting on axes of crystallographic symmetry,
but the expected disulfide bonds are not present. The distance
between the cysteine Ca positions of the two subunits is 11 A˚.
The crystals took over 6 months to grow, and we suspect
that the formate in the crystallization mixture may have slowly
reduced the disulfide bonds initially present (Gibson, 1969).
Based on the difficulties crystallizing this mutant, we do not view
it as a favorable candidate for future crystallization experiments.
D190C
As with the Q157C point mutation, D190C is located in a flexible
loop that is found to be disordered in many of the GFP structures
presented in this study. This mutant resulted in >20 conditions
with poorly diffracting crystals. We were still able to determine
the structures of three D190C mutants (PDB: 4W6G, 4W6H,
and 4W6I). PDB: 4W6I was the most symmetric dimer (171)
while PDB: 4W6G and 4W6H were asymmetric at 141 and
135, respectively (Figure 4G; Table 2).
Taking all the observed disulfide dimers together, we note that
only two of these are perfectly symmetric by virtue of lying on
crystallographic axes of 2-fold symmetry. Of those that did not
fall on symmetry axes, another nine had internal angles between
the chains >170 (11 of 36 disulfide dimers observed). The re-
maining majority of dimers were substantially asymmetric. This
contrasts with the trend toward nearly symmetric dimers noted
in earlier studies on synthetically symmetrized proteins (Banatao
et al., 2006; Forse et al., 2011) that had been connected primarily
through a-helical segments rather than a b-sheet conformation
as in GFP.
Design and Structure of Metal-Mediated GFP Oligomers
In addition to disulfide dimerization, we explored the possibility
of forming dimers or higher oligomers of GFP by designing
metal-binding half-sites on its surface. This second approach
follows from the work conducted by the groups of Tezcan and
Kuhlman (Salgado et al., 2008, 2010; Der et al., 2012). Here,
the idea is that introducing a metal half-site into the surface of
a protein will lead to assembly upon addition of metal. The utility
of themetal-mediated approach to synthetic symmetrization has
been demonstrated before, whereby it was found that, in addi-
tion to the intended dimeric forms, varied modes of assembly
can be realized upon metal addition (Laganowsky et al., 2011).
Previous efforts exploring engineered metal-mediated oligomer
formation have focused on mutations in a-helical proteins. In
those cases, residues i and i+4 can be mutated to metal-
chelating residues. The mutations are typically to His/His or
His/Cys pairs in an attempt to replicate native chelation motifs.
We investigated whether a variation of the approach could be
applied to GFP, which consists mainly of a single b barrel. WeStructure 23, 1754–17selected residues in three distinct regions of the protein to
mutate to either His/His or His/Cys pairs. These mutations
were residues i and i+2 on one b strand (E124/K126) or two res-
idues on adjacent strands (D21/K26 and E115/T118) (Figure 2C).
To evaluate their ability to form oligomers in the presence of
metal ions, we analyzed purified proteins in the presence of
Cu2+, Ni2+, and Zn2+ salts using native gel-shift assays. Addi-
tional metal ions (e.g. Fe2+, Fe3+, Cd2+, andCo3+) were screened,
but these metals either indicated no oligomer formation or had
non-reproducible results by our native gel-shift assay and were
not pursued for crystallization studies. We determined that
mutant pairs D21H/K26C, E115C/T118H, E124H/K126C, and
E124H/K126H were all able to form oligomers in the presence
of each of the ions (Figure 2D). All of these mutant-metal combi-
nations were then used for crystallization experiments to deter-
mine their ability to sample different space groups and form
metal-mediated crystal contacts. Although D21H/K26H and
E115H/T118H did not show shifts on the native gel assay, we
proceeded with the crystallization experiments to determine
whether they could still form metal-mediated contacts during
the crystallization process.
From these metal-mediated variants we solved seven unique
structures that were dependent on metal chelation to form. As
with the disulfide and mixed disulfide-metal dimers, an ability
to crystallize in a variety of conditions was observed. In a range
of other cases, however, the metal ions established crystal con-
tacts between different GFPmolecules through a combination of
the engineered residues and other native residues (typically Asp
and Glu) on the protein surface. Only one of these structures
(PDB: 4W7R) formed a symmetric dimer, whereas the other
cases involved more complex spatial arrangements. In several
cases, owing to low resolution and poor electron density, it
was difficult to determine the exact chelation of the metal ion
by the protein side chains. In some instances this likely results
from exposure to synchrotron radiation, which can change the
oxidation state of metal ions or damage carboxylic acid groups
in the chelating aspartic acid side chains (Carugo and Carugo,
2005; Weik et al., 2000).
D21H/K26C
The designed metal half-site mutation D21H/K26C resulted in
either disulfide dimers discussed previously or a mixed dimer
containing the disulfide and a chelated metal ion (PDB: 4W75,
4W76, 4W77, 4W7A, and 4W7C). Adjacent to the disulfide
bond, a copper ion is chelated by residues Asp19 and His21
from both participating protein chains (Figure 5B); the mutated
histidine was intended for chelation whereas the aspartate was
fortuitous. Some of the structures have poor electron density
for the Asp19 and His21 side chains, and it appears in some
instances that only one of the residues from each chain is
involved in the metal chelation. Structures PDB: 4W76, 4W77,
4W7A, and 4W7C are close to being symmetric (average angle
of 173.4), with PDB: 4W75 being more asymmetric at a 152
inter-subunit rotation. The symmetric structures are very similar
to each other, with a variation upon overlap of 2–8 (Figure 4B;
Table 2).
D21H/K26H
Two structures of this variant were obtained having copper-
mediated crystal contacts. In PDB: 4W7E, Asp19 and His21 of
one chain and Gln184 of the symmetry mate chelate the copper68, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1761
Figure 6. Crystals of Split-GFP with a Novel
Crystallization Target
(A) Crystals of the STARD9-10/11-GFP1-9 (D21H/
K26C) complex were obtained in a condition
composed of 10% v/v 2-propanol, 0.1 M MES
(pH 6.0), and 0.2 M Ca(OAc)2. The protein complex
was mixed in a 1:1 molar ratio with CuSO4 imme-
diately prior to the crystallization experiments. The
green color of the crystals is used as an indication
of the complex formation; the largest crystals
observed to date (20 mM in the largest dimension)
are highlighted by the red circle.
(B) Crystals of a designed protein with an en-
gineered internal (10–11) hairpin in complex with
GFP1-9 (D117C). The triangular plate crystals
(50–75 mM) grew in a condition containing 0.1 M
SPG buffer (pH 5.0) and 25% w/v PEG1500.ion. This mutant crystallized in the presence of imidazole, leading
to one imidazole molecule also being bound to the copper ion.
Structure PDB: 4W7D features two different copper-mediated
contacts (Figure 5C), and two chains are present in the asym-
metric unit. Chain A makes contacts with two different protein
molecules in the crystal using side chains that were engineered
into this mutant. First, His21 and His26 chelate two copper
ions and form a crystal contact to Lys3 of one neighboring mole-
cule. A crystal contact to a different molecule is through Lys2 of
chain A and Asp19 and His21 of the other protein, similar to the
metal chelation observed in the D21H/K26C structures. The high
pH (9.5) of this crystallization condition allows the lysine side
chain to participate in the chelation of the copper ion.
E115C/T118H
In addition to the observed disulfide dimers of this mutant, struc-
ture PDB: 4W74 forms a complex system of metal-mediated
crystal contacts between the eight protein chains in the asym-
metric unit and six zinc ions via three different coordination sites
(Figure 5D). The mutated Cys115/His118 half-site is found to
chelate the zinc to a lone Cys115 in two cases; between chain
A (Cys115/His118) and chain G (Cy115), and chain D (Cys115/
His118) to chain F (Cys115). The Cys115/His118 half-site and
an aspartic acid residue from a neighboring protein molecule
chelate the other four zinc ions in arrangements that are gener-
ally similar to each other.
E115H/T118H
Two crystal forms of the E115H/T118H mutant with two different
metal-mediated contacts were solved. PDB: 4W6U contains four
chains in the asymmetric unit, yet only chains A and B feature a
nickel-mediated contact. His118 of chain A and His115 of chain
B are the residues responsible for metal chelation, along with
a citrate molecule from the crystallization buffer (Figure 5E). A
second nickel atom is chelated by residues His25 and Glu132
of chain A alone. In the structure PDB: 4W6T there is one chain
in the asymmetric unit, which makes contact with other protein
molecules through two copper ions (Figure 5F). His115 of the first
chain and His25 and Glu132 of the symmetry mate chelate the
first copper atom. His118 and Glu32 of the first chain and
Asp133 of the symmetry mate chelate the second copper atom.
E124H/K126H
From the final mutant we determined two crystal structures,
PDB: 4W7F and 4W7R. PDB: 4W7F contains one chain in the
asymmetric unit with the copper-mediated contact formed1762 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltbetween His124/His126 of the first chain and Glu5 of the sym-
metry mate (Figure 5G). The only symmetric metal-mediated
dimer for which we obtained a structure is PDB: 4W7R. In this
case the His124/His126 pair from chain A chelates a copper
ion together with the His124/His126 pair from chain B. Two
copper-mediated dimers (four subunits in total) are found in
the asymmetric unit, and both dimers are nearly symmetric
with chains orientated 179 apart. The two dimers are virtually
identical, with only a 2 variation when aligned.
GFP Oligomers as a Crystallization Scaffold
After establishing in a previous study that a complex between the
split-GFP(1–9) and a protein containing the (10–11) hairpin could
form diffraction-quality crystals (Nguyen et al., 2014), we set out
to crystallize a novel protein that had failed to crystallize in pre-
vious experiments. We attempted this with the motor domain
of STARD9 (Torres et al., 2011), a monomeric kinesin that could
serve as a target for novel anti-mitotic drug development. We
co-expressed a construct of STARD9 as an N-terminal fusion
to the GFP(10–11) hairpin together with the four metal-chelating
GFP(1–9) mutants that consistently showed oligomerization
in the native gel experiments (K26C/D21H, E124H/K126H,
E124H/K126C, and E115C/T118H). Of the four experiments
attempted, only K26C/D21H&E124H/K126H gave robust
complementation. We were able to obtain crystals of the
STARD9-10/11 and GFP1-9 (D21H/K26C) complex after
approximately 3 months (Figure 6A). However, these crystals
are small (20 mM in the largest dimension) and have not pro-
duced well-ordered diffraction to date; optimization efforts are
under way.
A second computationally designed 271-amino-acid protein
(to be published) containing the (10–11) hairpin as a loop inser-
tion was co-expressed with the cysteine mutant suite of split-
GFPs, all of which resulted in robust complementation. After
7 months, triangular plate crystals (50–75 mM) (Figure 6B)
were observed containing the designed protein in complex
with the GFP1-9 (D117C). As with the STARD9-10/11 con-
structs, optimization efforts of these crystals are under way.
DISCUSSION
The structural results presented here characterize a suite of en-
gineered GFP molecules comprising a wide range of oligomericd All rights reserved
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Figure 7. Alternative Applications for Engi-
neered Oligomeric GFPs
Beyond their proposed utility as carriers for the
crystallization of novel proteins, other potentially
useful applications are possible.
(A) Fusion to GFP dimers could be used to change
the crystal forms of existing proteins. Here a
disordered crystal (top) can form a different and
possibly better-ordered lattice (bottom) through
fusion to one of the GFP oligomers in the available
suite.
(B) Fusion to a multimeric enzyme, in this example
a tetramer, could be used to create an enzymati-
cally active amorphous gel for facile separation
of enzymes and products for in vitro reaction
systems.
(C) With the split form or through terminal fusions,
the GFP dimers could be used to create a heter-
odimer for co-localization of enzymes for substrate
channeling or co-crystallization experiments.
(D) Expanding on the idea from (C), two proteins
can be forced into close proximity and further
symmetrized, by separate genetic fusion of strand
10 to one protein and strand 11 to the other,
then allowing them to complement for various
applications.forms, most of which appear highly amenable to crystallization
on their own. We obtained 20 new crystal forms of seven disul-
fide-bonded dimers, plus 13 metal-mediated structures from
five combinations of metal-chelating mutations in the presence
of different metals. The 33 crystal forms are all distinct from
each other (Table 1). Many of the engineered GFPs formed addi-
tional crystal forms in numerous conditions that were not
pursued for structure determination. In analyzing individual
GFP variants that were observed in multiple crystal forms, it
was found that some of the oligomeric GFPs show strong
geometric constraints between the disulfide-bonded subunits,
while others display considerable geometric polymorphism.
The K26C dimer was especially variable; among four instances
observed for that dimer, the smallest angular deviation between
any pair was 33. The D21H/K26C and D102 mutants were the
most rigid. Several instances of those dimers showed common
conformations within about 8 deviation, although individual
outliers were also obtained in both cases. The oligomeric GFP
molecules designed here have not yet been used to successfully
crystallize a target protein that was otherwise recalcitrant to
crystallization. Which of the GFP constructs might ultimately
be most useful in such a context is therefore presently unknown.
However, it is notable that a few of the constructs formed an
unusual number of distinct crystal forms readily. Among the di-
sulfide-based dimers, the D117C construct formed the most
(six) distinct crystal forms. Among the metal-mediated designs,
the E115H/T118H and D21H/K26H constructs each also formed
six distinct crystal forms.
The suite of oligomerizing GFP constructs designed here
could be used for crystallizing target proteins by direct fusion.
Alternatively, as noted above, our GFP constructs were engi-
neered to be compatible with use in split form so that engineered
variants of the GFP(1–9) construct can be reconstituted with a
target protein bearing the (10–11) hairpin. In principle, this recon-
stitution can be performed in vivo (by co-expression) or in vitroStructure 23, 1754–17(after separate purifications). Initial in vitro experiments using
the split forms of the oligomerizing GFP constructs (not pre-
sented here) suggest that further optimization of the GFP(1–9)
core may be important for stabilization in the context of the
various mutations introduced into the GFP sequence. The coun-
terbalancing advantages and disadvantages of the present
system will also have to be compared with other strategies.
For example, in some crystallization approaches the target
protein is potentially stabilized by its fusion to an intact scaffold
protein; attaching a small GFP fragment to a target protein (in the
split-complementation approach) is not likely to provide such an
advantage.
A principal long-term motivation for the present work is the
crystallization of novel proteins, but other diverse applications
in synthetic biology are likely to emerge for these oligomeric
variants of GFP (Figure 7). One prospective application would
be in attaching metabolically coupled enzymes together in
different geometries through metal-mediated interactions or
in vitro oxidized cysteines. They could be used as oligomerizing
scaffolds for bringing together homo- or hetero-pairs of proteins
into close proximity, in different spatial arrangements, and in
ways that can be triggered by the addition of metal ions (Figures
7C and 7D). To promote formation of strictly heteromeric assem-
blies, future experiments would be required to design asym-
metric versions of an oligomerizing carrier protein. Another
avenue for future applications will be in using oligomerizing
carrier proteins (GFP and others that could be developed) to
drive other proteins or enzymes to form extended materials or
amorphous gels (Figure 7B). While the motivating application
emphasized in the present study (protein crystallization) applies
primarily to target proteins that are naturally monomeric, we
envision that extended materials, most likely with irregular struc-
tures, could be formed by complementing various oligomeric
forms of the split-GFP(1–9) with naturally oligomeric proteins
or enzymes bearing the (10–11) hairpin. In most cases this68, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1763
Table 3. X-Ray Diffraction Data and Refinement Statistics
PDB: 4W69 4W6A 4W6B 4W6C 4W6D 4W6F 4W6G 4W6H 4W6I 4W6J 4W6K
Wavelength (A˚) 1.0717 0.9789 0.97918 0.9789 0.9793 0.9792 0.9793 1.0717 1.0717 0.9793 1.0717
Resolution
range (A˚)
94.58–3.975
(4.117–3.975)
77.02–2.991
(3.098–2.991)
44.69–1.895
(1.963–1.895)
71.3–2.492
(2.581–2.492)
87.16–3.447
(3.57–3.447)
84.34–2.701
(2.798–2.701)
69.09–3.024
(3.132–3.024)
82.72–1.953
(2.023–1.953)
53.59–2.625
(2.719–2.625)
98.5–1.702
(1.763–1.702)
75.46–2.877
(2.98–2.877)
Space group P 43 21 2 P 32 2 1 P 21 21 21 P 21 21 21 P 32 2 1 P 32 2 1 P 61 P 65 P 21 21 21 P 31 2 1 P 41 21 2
Unit cell 133.76 133.76
88.92 90 90 90
88.93 88.93
135.76
90 90 120
50.151 90.356
102.83 90
90 90
51.33 88.37
120.69
90 90 90
123.11 123.11
151.32 90
90 120
121.98 121.98
140.09 90
90 120
93.38 93.38
132.97 90
90 120
95.52 95.52
132.5 90
90 120
57.35 67.6
150.58
90 90 90
113.74,113.74
82.46 90
90,120
106.72 106.72
97.45 90 90 90
Total reflections 110,307
(10,414)
252,345
(23,254)
251,856 (13,789) 81,636
(7,060)
89,887
(8,957)
335,541
(32,238)
66,094
(6,525)
508,993
(47,571)
88,235
(6,817)
339,028
(33,029)
167,091
(13,967)
Unique reflections 7,344 (715) 12,990 (1,219) 37,298 (3,260) 19,311 (1,713) 17,869 (1,730) 33,538 (3,281) 12,859 (1,284) 49,488 (4,865) 17,334 (1,613) 67,258 (6,633) 13,200 (1,210)
Multiplicity 15.0 (14.6) 19.4 (19.1) 6.8 (4.2) 4.2 (4.1) 5.0 (5.2) 10.0 (9.8) 5.1 (5.1) 10.3 (9.8) 5.0 (4.2) 5.0 (5.0) 12.7 (11.5)
Completeness (%) 99.90 (99.31) 99.52 (95.08) 98.40 (87.52) 97.33 (88.79) 99.26 (98.69) 99.95 (99.64) 99.74 (99.46) 99.80 (98.06) 95.43 (82.54) 99.47 (98.82) 99.25 (93.51)
Mean I/s(I) 16.9 (2.1) 20.3 (2.5) 12.3 (4.5) 7.3 (1.9) 11.91 (1.7) 5.6 (2.0) 16.7 (2.4) 16.4 (2.9) 5.9 (1.0) 16.6 (2.1) 22.1 (2.6)
Wilson B factor 162.1 72.3 20.6 60.3 112.8 64.4 95.5 25.4 54.4 25.2 91.6
Rmerge 0.144 (1.663) 0.162 (1.385) 0.104 (0.376) 0.104 (0.660) 0.118 (1.023) 0.304 (0.578) 0.064 (0.729) 0.109 (0.819) 0.246 (1.047) 0.051 (0.702) 0.083 (1.265)
Rmeas 0.149 0.167 0.113 0.118 0.132 0.321 0.072 0.114 0.273 0.057 0.087
CC1/2 0.999 (0.714) 0.999 (0.767) 0.995 (0.871) 0.989 (0.881) 0.998 (0.607) 0.955 (0.871) 0.998 (0.853) 0.998 (0.811) 0.983 (0.853) 0.999 (0.782) 0.999 (0.811)
CC* 1 (0.913) 1 (0.932) 0.999 (0.965) 0.997 (0.968) 1 (0.869) 0.988 (0.965) 1 (0.959) 1 (0.947) 0.996 (0.959) 1 (0.937) 1 (0.946)
Rwork 0.307 (0.457) 0.191 (0.304) 0.167 (0.201) 0.248 (0.443) 0.236 (0.363) 0.204 (0.258) 0.248 (0.384) 0.166 (0.200) 0.268 (0.504) 0.189 (0.259) 0.249 (0.351)
Rfree 0.335 (0.398) 0.240 (0.389) 0.202 (0.280) 0.276 (0.445) 0.267 (0.318) 0.238 (0.290) 0.270 (0.361) 0.190 (0.229) 0.316 (0.606) 0.212 (0.289) 0.294 (0.395)
No. of non-
hydrogen atoms
3,458 3,574 3,867 3,553 3,550 3,604 3,505 3,884 3,558 3,925 3,037
Macromolecules 3,414 3,530 3,599 3,509 3,505 3,539 3,461 3,635 3,514 3,623 2,993
Ligands 44 44 47 44 45 65 44 44 44 96 44
Water 0 0 221 0 0 0 0 205 0 206 0
Protein residues 434 446 454 443 445 445 437 457 443 451 378
RMS (bonds) 0.011 0.018 0.009 0.01 0.01 0.011 0.011 0.011 0.014 0.011 0.011
RMS (angles) 1.29 1.6 1.08 1.29 1.69 1.37 1.37 1.21 1.3 1.21 0.95
Ramachandran
favored (%)
97 97 98 96 98 97 97 98 97 99 97
Ramachandran
outliers (%)
0 0.23 0 0.23 0.7 0.23 0.48 0 0 0 0.29
Clashscore 21.2 14.2 1.4 12.2 17.5 6.2 21.2 1.5 5.4 4.9 9.3
Average B factor 191.0 64.0 25.0 63.0 124.1 68.6 171.7 26.9 56.1 33.9 94.8
Macromolecules 191.5 64.1 24.9 63.2 124.3 68.4 171.7 26.8 56.3 33.5 35.1
Ligands 147.9 54.6 18.5 50 107.6 77.1 175.5 20.1 42.6 38.9 78.3
Solvent – – 27.8 – – – – 30.7 – 37.1 –
(Continued on next page)would lead to runaway oligomerization, yielding materials with
potentially novel properties and uses. Other synthetic biology
applications may benefit from higher-order oligomers. Based
on our crystal structures, there are possible interfaces that could
be mutated to achieve this purpose. As an example, a novel
tetrameric form of GFP could be based on the structure of the
D117C mutant PDB: 4W6M. This structure features a tetramer
composed of two symmetric dimers in the asymmetric unit
of the crystal. Further mutations in the region of the fortuitous
interaction between dimers (residues I206, S146, and N147),
either via metal-mediated interactions or by computational
sequence design of a more extensive interface, could create a
higher oligomeric form of GFP.EXPERIMENTAL METHODS
Cloning
Unless otherwise stated, primers were ordered from Valuegene, enzymes
were from New England Biolabs, and DNA sequencing was performed by
Genewiz. The plasmid construct containing the split-GFP (Cabantous1764 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltet al., 2005, 2013) was used as a template to generate a construct with a
C-terminal hexahistidine tag and the C terminus: . TAAGITHHHHHH. The
GFP gene was PCR amplified with Phusion DNA polymerase using
the primers GFP.For and GFP.Rev, which include NdeI and HindIII
restriction sites, respectively, in the primer extensions. The PCR-amplified
segment was purified, digested with NdeI and HindIII, and ligated into
pET24a, which had been restriction digested with the same two
enzymes. Colony PCR using T7 and T7 terminator primers was performed
to identify putative positive clones whose DNA sequences were subse-
quently confirmed by DNA sequencing. Two cysteine residues (Cys48,
Cys70) were mutagenized to alanine using the primers C48A.For.New./
C48A.Rev.New. and C70A/C70A_antisense to eliminate the possibility of un-
intended disulfide bonds. The C48A mutation was made by linear PCR
amplification of the target vector with Phusion DNA polymerase, followed
by DpnI digestion of the template plasmid and subsequent phosphorylation
of the gel-extracted DNA with T4 polynucleotide kinase and ligation with
T4 DNA ligase. The C70A mutation was made using Pfu Turbo AD polymer-
ase (Agilent) using the Quikchange mutagenesis procedure. Additional muta-
tions were made in the GFP construct containing the C48A/C70A mutations
by the Quikchange method to generate the following GFP mutant proteins:
C48A/C70A/D102C, C48A/C70A/D117C, C48A/C70A/Q157C, C48A/C70A/
K26C, C48A/C70A/D190C, C48A/C70A/E124H/K126H, and C48A/C70A/
E115C/T118H.d All rights reserved
4W6L 4W6M 4W6N 4W6O 4W6P 4W6R 4W6S 4W6T 4W6U 4W72 4W73 4W74
1.0717 0.9793 0.9537 0.9793 0.9793 0.9792 0.9789 0.9795 0.9795 0.9795 0.9789 0.9795
76.67–2.45
(2.538–2.45)
73.83–2.793
(2.893–2.794)
88.89–3.375
(3.496–3.375)
67.51–2.6
(2.693–2.6)
79.58–3.085
(3.195–3.085)
89.88–3.471
(3.595–3.471)
68.28–3.1
(3.211–3.1)
74.46–1.604
(1.661–1.604)
82.99–2.278
(2.36–2.278)
57.12–1.996
(2.067–1.996)
52.18–2.787
(2.887–2.787)
88.27–2.099
(2.174–2.099)
I 41 2 2 P 63 C 1 2 1 P 64 2 2 P 21 21 21 P 1 P 43 21 2 P 43 21 2 P 21 21 21 P 21 21 21 P 21 21 21 P 1 21 1
108.43 108.43
101.47 90
90 90
170.5 170.5
79.57 90
90 120
181.21 102.68
84.13 90
101.44 90
77.95 77.95
178.88 90
90 120
86.05 117.86
209.1 90 90 90
92.42 92.56
124.53 94.94
96.17 102.25
91.51 91.51
205.11
90 90 90
105.3 105.3
69.61 90
90 90
47.64 116.58
165.98 90
90 90
72.54 74.4
89.15 90
90 90
69.74 70.58
77.5 90 90 90
67.44 119.79
130.57
90 89.99 90
148,335
(14,256)
63,420
(1,852)
70,644
(6,362)
160,637
(16,471)
261,903
(23,019)
87,921
(8,257)
418,083
(42,445)
653,315
(63,113)
279,406
(25,897)
238,183
(20,955)
62,325
(4,525)
411,267
(39,095)
11,419 (1,106) 32,658 (378) 20,957 (1964) 10,518 (991) 39,143 (3,478) 46,082 (4,386) 16,549 (1,612) 51,580 (4,985) 42,930 (4,011) 33,399 (3,272) 9,864 (848) 119,482 (11,56
13.0 (12.9) 5.7 (4.9) 3.4 (3.2) 15.3 (16.6) 6.7 (6.6) 1.9 (1.9) 25.3 (26.3) 12.7 (12.7) 6.5 (6.5) 7.1 (6.4) 6.3 (5.3) 3.4 (3.4)
99.83 (98.57) 99.15 (95.61) 97.89 (91.99) 99.94 (99.70) 97.98 (88.91) 89.44 (85.24) 99.95 (99.94) 99.78 (97.98) 99.28 (94.55) 99.74 (98.55) 98.67 (87.69) 98.81 (95.89)
23.9 (3.4) 4.8 (3.8) 6.6 (1.5) 26.0 (3.4) 10.8 (2.2) 5.7 (1.4) 18.0 (3.6) 17.8 (1.6) 14.2 (1.9) 16.6 (2.4) 10.1 (1.7) 8.1 (1.5)
61.8 71.3 84.6 68.9 70.7 101.5 76.2 26.5 44.6 41.2 73.9 32.2
0.064 (0.840) 0.766 (0.789) 0.205 (0.778) 0.072 (0.934) 0.149 (0.847) 0.095 (0.467) 0.257 (1.844) 0.072 (1.129) 0.105 (0.906) 0.060 (0.821) 0.109 (0.851) 0.104 (0.775)
0.067 0.823 0.244 0.075 0.162 0.134 0.262 0.075 0.115 0.065 0.119 0.123
0.999 (0.979) 0.683 (0.49) 0.992 (0.746) 0.999 (0.938) 0.994 (0.76) 0.989 (0.773) 0.998 (0.947) 0.999 (0.821) 0.997 (0.739) 0.999 (0.895) 0.996 (0.70) 0.996 (0.747)
1 (0.995) 0.901 (0.811) 0.998 (0.924) 1 (0.984) 0.999 (0.929) 0.997 (0.934) 1 (0.986) 1 (0.95) 0.999 (0.922) 1 (0.972) 0.999 (0.908) 0.999 (0.925)
0.252 (0.375) 0.261 (0.389) 0.316 (0.400) 0.262 (0.348) 0.232 (0.315) 0.307 (0.409) 0.223 (0.284) 0.180 (0.260) 0.210 (0.277) 0.190 (0.292) 0.221 (0.366) 0.212 (0.303)
0.278 (0.450) 0.285 (0.394) 0.363 (0.469) 0.311 (0.415) 0.279 (0.363) 0.357 (0.431) 0.276 (0.372) 0.207 (0.289) 0.250 (0.319) 0.235 (0.314) 0.297 (0.464) 0.235 (0.330)
1,635 6,752 10,419 1,662 12,960 25,002 3,538 2,074 7,317 3,817 3,519 14,583
1,613 6,652 10,331 1,637 12,828 25,002 3,442 1,846 7,083 3,570 3,469 14,200
22 100 88 22 132 0 96 69 111 45 50 182
0 0 0 3 0 0 0 159 123 202 0 201
205 842 1,306 208 1,618 3,133 436 227 890 450 437 1,793
0.01 0.011 0.009 0.013 0.009 0.008 0.012 0.019 0.012 0.011 0.013 0.013
1.23 1.2 1.49 1.85 1.42 1.76 1.55 1.7 1.36 1.24 1.42 1.51
96 99 95 98 97 96 95 99 98 98 97 98
0 0.12 0.08 0 0.13 0.44 0.47 0 0.12 0 0 0
8.1 14.0 30.0 20.8 12.6 20.0 21.6 6.3 4.5 3.2 13.7 7.2
93.1 91.1 33.4 106.4 80.1 113.2 84.2 32 47.4 46.4 67.8 39.1
93.3 91.4 99.6 106.6 80.2 113.2 84 31 47.7 46.2 67.9 39.1
79.2 72 72.8 97.2 70.6 – 91 42 36.4 42.4 55.9 36.3
– – – 72 – – – 39.7 43.8 50.5 – 37.1
Table 3. Continued
(Continued on next page)Proteins with an N-terminal tobacco etch virus (TEV) protease cleavable
His6 tag were constructed by cloning the existing GFP mutants in pET24
into a modified pET28 vector with N-terminal cleavable tag to add the
N-terminal sequence: MGSDKIHHHHHHENLYFQG. In brief, the primers
GFP.pMA507-star.For. and GFP.pMA507-star.Rev. were used to PCR
amplify the mutated GFP DNA segments; the DNA was gel extracted and
cloned into pMA507star by the Gibson ISO assembly method (Gibson et al.,
2009). pMA507-star was PCR amplified with the primers PIPE.Vec.For. and
PIPE.Vec.Rev. to generate compatible DNA overhangs. Primer sequences
used are presented in Table S4.
Protein Expression
Plasmids containing mutant GFP genes were transformed into Escherichia coli
BL21-DE3 expression cells (New England Biolabs). 10-ml starter cultures
were grown with overnight shaking at 37C in LB media containing appro-
priate antibiotics. The starter culture was used to inoculate 1 l of terrific broth
medium supplemented with 20 ml 503 5052 auto-induction sugars (Studier,
2005) and appropriate antibiotics. Cultures were grown for 4 hr at 37C. The
temperature was then reduced to 30C, and cultures were allowed to grow
for approximately 20 hr. After growth, the cultures were centrifuged at
5,000 3 g for 30 min at 4C. Harvested cell paste was stored at 80C until
purification.Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 176)Protein Purification
Cell paste was thawed at room temperature in a lysis buffer of 20 mM Tris
(pH 8.0), 200 mM NaCl, 10 mMMgCl2, 30 mM Imidazole, 400 mg/ml lysozyme,
10 mg/ml DNAse, and 1 mM AEBSF (4-(2-aminoethyl)benzenesulfonyl fluoride
hydrochloride). Once the pellet was thawed, cells were lysed via sonication.
Lysed cells were incubated at room temperature for 15 min prior to centrifuga-
tion to remove all insolublematerial, and lysates were clarified at 25,0003 g for
30 min at 4C. The soluble lysate fraction was applied to a 5 ml Ni-nitrilotriace-
tic acid (IMAC) column, rinsed with 10 column volumes of wash buffer consist-
ing of 20 mM Tris (pH 8.0), 250 mM NaCl, and 30 mM imidazole. The protein
was eluted from the column with wash buffer containing 250 mM imidazole.
Elution fractions were pooled and then concentrated until the final volume
was approximately 1 ml. For the disulfide dimers, the protein was exchanged
into a buffer consisting of 20 mM Tris (pH 9.0) and 100 mM NaCl. Cysteines
where then oxidized to form dimers by the addition of 10 ml of dimerization
buffer (20 mM Tris [pH 9.0], 100 mM NaCl, 5 mM CuSO4). This oxidation reac-
tion was incubated at room temperature for 15 min before being quenched by
the addition of 50mMEDTA. To separate newly formed dimers from remaining
monomers, the protein was dialyzed overnight at 4C into anion exchange
buffer (10 mM Tris [pH 9.5], 1 mM EDTA). The protein was applied to an anion
exchange column and then eluted via a salt gradient of 0–1 M NaCl in anion
exchange buffer. The major peak for each cysteine mutant was assessed for65
4W7X 4W75 4W76 4W77 4W7A 4W7C 4W7D 4W7E 4W7F 4W7R
0.9789 1.0717 0.9792 0.9789 0.9792 0.9795 0.9792 0.9792 0.9789 0.9789
66.77–2.8
(2.9–2.8)
69.13–3.47
(3.597–3.473)
60.5–2.345
(2.429–2.345)
60.79–3.1
(3.211–3.1)
96.28–3.603
(3.731–3.603)
96.15–2.5
(2.59–2.5)
66.57–1.799
(1.863–1.799)
67.92–2.592
(2.685–2.592)
48.76–2.9
(3.004–2.9)
92.07–1.799
(1.863–1.799)
P 1 21 1 P 21 21 21 P 21 21 21 P 21 21 21 P 21 21 21 C 1 2 1 P 21 21 21 P 41 21 2 C 2 2 21 P 1 21 1
66.84 70.47
116.78 90
92.56 90
59.86 83.93
121.88 90
90 90
64.16 66.84
121 90 90 90
62.12 68.29
121.58 90
90 90
120.83 121.33
192.56 90
90 90
205.49 69.42
102.81 90
110.73 90
56.42 82.05
113.87 90
90 90
96.05 96.05
69.96 90
90 90
68.2 69.75
82.57 90
90 90
62.67 87.19
92.07 90
90.01 90
183,888
(18,230)
104,617
(8,741)
145,381
(13,147)
63,735
(6,380)
220,621
(21,172)
321,515
(31,440)
326,510
(29,374)
134,951
(13,211)
23,617 (1523) 306,630 (30,073)
26,887 (2,649) 8,254 (755) 22,306 (2,125) 9,841 (949) 33,244 (3,177) 46,757 (4,596) 49,634 (4,736) 10,580 (999) 4,558 (378) 90,790 (8,888)
6.8 (6.9) 12.7 (11.6) 6.5 (6.2) 6.5 (6.7) 6.6 (6.7) 6.9 (6.8) 6.6 (6.2) 12.8 (13.2) 5.4 (4.0) 3.4 (3.4)
99.66 (99.62) 98.78 (94.83) 99.23 (96.33) 99.87 (99.79) 99.40 (95.49) 99.06 (97.93) 99.57 (96.26) 99.68 (97.18) 99.52 (99.55) 98.83 (97.73)
8.2 (1.6) 13.6 (1.7) 10.1 (1.8) 9.9 (2.6) 13.9 (2.3) 15.6 (1.9) 8.8 (1.0) 19.8 (2.0) 8.0 (4.0) 6.4 (1.2)
57.1 125.6 47.9 69.4 112.5 63.2 25.9 58.9 82.4 23.5
0.190 (1.297) 0.150 (1.419) 0.110 (1.015) 0.151 (0.748) 0.122 (0.799) 0.073 (1.03) 0.138 (1.868) 0.113 (1.67) 0.178 (0.405) 0.122 (1.021)
0.205 0.156 0.119 0.165 0.133 0.079 0.15 0.118 0.196 0.145
0.991 (0.616) 0.999 (0.944) 0.998 (0.924) 0.996 (0.814) 0.998 (0.804) 0.999 (0.917) 0.997 (0.451) 0.999 (0.792) 0.98 (0.826) 0.994 (0.71)
0.998 (0.873) 1 (0.985) 1 (0.98) 0.999 (0.947) 0.999 (0.944) 1 (0.978) 0.999 (0.789) 1 (0.94) 0.995 (0.951) 0.998 (0.911)
0.217 (0.317) 0.301 (0.444) 0.233 (0.424) 0.217 (0.260) 0.278 (0.336) 0.226 (0.408) 0.179 (0.317) 0.207 (0.3534) 0.264 (0.404) 0.223 (0.376)
0.269 (0.386) 0.345 (0.377) 0.288 (0.459) 0.291 (0.377) 0.302 (0.337) 0.254 (0.428) 0.221 (0.342) 0.262 (0.441) 0.332 (0.439) 0.253 (0.425)
7,089 3,181 3,639 3,474 7,085 7,028 4,014 1,820 1,726 7,625
7,001 3,180 3,588 3,473 6,994 6,938 3,603 1,766 1,703 7,166
88 1 45 1 91 90 103 28 23 146
0 0 6 0 0 0 309 26 0 313
882 396 452 432 881 873 224 222 215 677
0.009 0.004 0.011 0.01 0.011 0.013 0.01 0.012 0.01 0.012
0.93 0.85 1.28 1.4 1.22 1.33 1.26 1.46 1.37 1.27
97 98 99 94 96 99 97 97 97 99
0.23 0 0 0.24 0.35 0 0 0 0 0
11.3 4.1 9.1 12.4 8.0 15.0 4.0 7.1 10.9 6.0
50.7 161.6 64.7 65.2 117.2 100.1 21.3 52.7 74.7 33.5
50.8 161.6 64.8 65.2 118.2 100.3 30.4 52.8 75 33.2
43.3 196.4 61.1 64.9 42.2 83.9 39.9 53.4 51 37.1
– – 56.8 – – – 39 46.2 – 38
CC1/2, correlation coefficient between intensities of crystallographic random half-datasets; CC*, correlation coefficient of the full dataset derived from
CC1/2.
Table 3. Continueddimer purity by non-reducing SDS-PAGE. Fractions of homogeneous dimers
were pooled, buffer exchanged into GFP crystallization buffer (10 mM Tris,
100 mM NaCl), then concentrated to 20 mg/ml. Aliquots of protein were
flash-frozen in liquid nitrogen and stored at 80C for subsequent crystal
trials.
Metal-mediated mutants were purified using the same method, up to the
IMAC purification, where the hexahistidine tag was cleaved off with TEV pro-
tease overnight at 4C in TEV cleavage buffer (10 mM Tris [pH 8.0], 100 mM
NaCl, 5 mM DTT, 1 mM EDTA). Cleaved protein was then subject to a second
IMAC step to remove the TEV protease, cleaved histidine tag, and any un-
cleaved protein. All unbound protein was pooled, buffer exchanged into crys-
tallization buffer, concentrated to 40 mg/ml, flash-frozen, and stored at80C
for future crystal trials.
Co-expression with Target Proteins
The STARD9-10/11 construct consisted of the N-terminal TEV protease cleav-
able His6 tag (MGSDKIHHHHHHENLYFQG) followed by the (10–11) hairpin
sequence, DLPDDHYLSTQTILSKDLNEKRDHMVLLEYVTAAGITDAS, with
the ‘‘DAS’’ serving as a linker between the hairpin and target protein as previ-
ously described (Nguyen et al., 2014). Only the first 391 amino acids (Met1–
Asn391) corresponding to the putative motor domain of the protein were
used in this construct.1766 Structure 23, 1754–1768, September 1, 2015 ª2015 Elsevier LtFor the prospective designed protein construct, the GFP (10–11) hairpin was
inserted into a presumptive loop between Ser135 and Thr136 of the native
271-amino-acid protein. This construct features a non-cleavable C-terminal
His6 tag, and as such was not used for the metal-mediated experiments.
The expression and purification methods for the co-expressed GFP(1–9)
and crystallization targets with the (10–11) hairpin were essentially the same
as for the GFPs alone. After size-exclusion chromatography, the fractions
with approximate 1:1 molar ratio of GFP(1–9) and target protein (visualized
by SDS-PAGE) were used for the crystallography experiments.
Crystallization
TheGFP oligomerswere crystallized using hanging-drop vapor diffusion. Initial
experiments were carried out at the UCLA crystallization facility using com-
mercial sparse matrix screens in a 96-well format. All initial screening trays
were set using a Mosquito liquid handling device (TPP LabTech). Limited op-
timizations were performed manually in some cases using 24-well Linbro
plates. Each disulfide dimer was screened initially with four commercial sparse
matrix screens JCSG+ (Qiagen), SaltRx (Hampton Research), Crystal Screen
I + II (Hampton Research), and Wizard I + II (EmeraldBio). Metal-mediated mu-
tations were screened with JCSG+ andWizard only. The final concentration of
protein in all crystallization experiments was 20 mg/ml. Metal-mediated mu-
tants were mixed with the metal ions (Ni2+, Zn2+, or Cu2+, in three separated All rights reserved
screens) immediately before setting crystal trays, at a final concentration
of 20 mg/ml protein and 2 mMmetal ion salts. Trays were set at room temper-
ature and checked periodically over 30 days. Single crystals were mounted
with CrystalCat HT Cryoloops (Hampton Research), cryoprotected as needed,
flash-frozen with liquid nitrogen, and screened for diffraction. All diffracting
crystals were stored for later data collection. All diffraction data were collected
at 100 K at APS-NECAT beamline 24-ID-C on a DECTRIS-PILATUS 6M detec-
tor. The crystallization and cryoprotectant conditions are reported in Table S5.
Structure Determination
Datasets from individual crystals were indexed, integrated, and scaled using
XDS/XSCALE (Kabsch, 2010), with the resolution limit selected to balance
completeness, calculated I/s, Rsym, and CC1/2 of the highest-resolution shell
with emphasis on I/s values of >1.5 and CC1/2 values of >0.9. Structures
were solved by molecular replacement using the program Phaser (McCoy
et al., 2007), with the superfolder GFP (Pe´delacq et al., 2006) protein
(PDB: 2B3P) as the search model. To accelerate the model building and
refinement, molecular replacement solutions were initially refined with the
PDB_REDO server (Joosten et al., 2011). Final iterative rounds of model build-
ing and refinement were carried out using Coot (Emsley et al., 2010) and
PHENIX (Adams et al., 2010) with TLS refinement (Painter and Merritt, 2006).
Structures were validated with PROCHECK (Laskowski et al., 1993), ERRAT
(Colovos and Yeates, 1993), MolProbity (Davis et al., 2007), and VERIFY3D
(Luthy et al., 1992). Atomic coordinates and structure factors for all 33 struc-
tures were deposited in the PDB. Figures depicting the structures were
made with PyMOL (Schro¨dinger). Data collection and refinement statistics
are given in Table 3.
Structure Comparison Procedure
To compare multiple observed instances of the same disulfide-bonded dimer,
one structure was first chosen as the reference. Then one chain of a subse-
quent dimer was aligned to chain A of the reference dimer, and the transforma-
tion required for overlapping those two chains was applied to the second
chain. Both possible assignments to chain A versus chain B were tested for
each dimer, and the best match was retained for comparison. These optimal
chain assignments do not necessarily correspond to chain assignments in
the deposited PDB files.
ACCESSION NUMBERS
Atomic coordinates and structure factors for all 33 structures in this
study were deposited, under accession numbers PDB: 4W69, 4W6A, 4W6B,
4W6C, 4W6D, 4W6F, 4W6G, 4W6H, 4W6I, 4W6J, 4W6K, 4W6L, 4W6M,
4W6N, 4W6O, 4W6P, 4W6R, 4W6S, 4W6T, 4W6U, 4W72, 4W73, 4W74,
4W7X, 4W75, 4W76, 4W77, 4W7A, 4W7C, 4W7D, 4W7E, 4W7F, and 4W7R.
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